Apple mistletoe / Copper carbonate solution for injection 1ml ampoules
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
7 branded products available
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 12 studies.
Reviews & meta-analyses: 2 · 2005–2025
Showing all 12 studies, sorted by most relevant.
Mopai MG, Mpai S, Van Staden J, et al.
2025
- Mistletoe
- Plant Extracts
- Ethnopharmacology
Mistletoe species grow hemiparasitically on a wide spectrum of trees occurring in the tropical, subtropical and temperate zones. Mistletoe has been associated with fertility, vitality and fatality in humans. In the present review, we examine articles published in English and/or with the option to translate them into English on the distribution mechanism, ecological impact and value. This study aimed to interrogate and outline the phytonutrient profiling, ethnomedicinal and ethnopharmacological applications, toxicology and quality control of mistletoes, particularly the Loranthaceae and Viscaceae families. There are at least 1400 species of mistletoe belonging to these two families across the world. Humans have used mistletoe for years, and it has a rich history, mainly in traditional medicine. Recent research interests accompanied by investigations on mistletoe have made a major contribution to our understanding of the survival behavior and mechanisms of the species. This has prompted researchers to intensively investigate and justify its potential and applications in traditional medicine systems to further incorporate it into conventional scientific medicine processes. This study thoroughly outlines the nutritional and phytochemical constituents of various mistletoe species, as well as the factors that play a role in the process. The sections in this study dedicated to elaborating on the nutritional and phytochemical composition of mistletoe show that it is a plant species rich in nutrients and bioactive compounds, especially compared to its host. Its survival mechanism makes it possible for this plant species to contain significant quantities of both nutrients (proximate components and mineral elements) and bioactive compounds (viscin, alkaloids, phenolics and polyphenolics, tannins, flavonoids, terpenoids, glycosides, and saponins). Overall, mistletoe species have potential as medicinal plants, offering a range of health benefits and the ability to treat ailments (both communicable and non-communicable diseases). However, there are insufficient investigations and records of mistletoe's toxicity, safety and quality control. Therefore, it is important to further investigate the potential applications, mechanisms of action, and optimal uses of mistletoe preparations and/or extracts.
Abstract licence: CC BY
A. Q. Ganai, M. A. Dar, M. Chesti, et al.
Current Journal of Applied Science and Technology, 2020
Nadia Lyousfi, Ikram Legrifi, Nabil Ennahli, et al.
Journal of Fungi, 2023
Günther A, Bednarczyk-Cwynar B
2025
This review discusses the antioxidant potential of oleanolic acid, a triterpene compound present in many medicinal and edible plants. The authors analyze various studies that confirm numerous pharmacological properties of this compound, such as its anticancer, antidiabetic, neuroprotective, osteoprotective, anti-obesity, and anti-inflammatory effects. OA, as a natural antioxidant, plays an important role in neutralizing reactive oxygen species, which contribute to the oxidative stress that is responsible for the development of many diseases, including cancer and cardiovascular and neurodegenerative diseases. This article also presents natural sources of OA, including grapes, olives, and apples, and discusses the mechanisms of its antioxidant action, including the inhibition of lipid peroxidation and the modulation of signaling pathways related to inflammatory processes. In addition, there are research results that indicate the therapeutic benefits of OA in the treatment of diabetes and neurodegenerative diseases, as well as its potential to protect the heart, liver, and kidneys from oxidative damage. In conclusion, OA has potent antioxidant properties that can be used in the prevention and treatment of many diseases related to oxidative stress. This article also presents the possibility of increasing the bioavailability of OA through the use of nanoparticle and liposome technology.
Abstract licence: CC BY
Annika Mascher, Florian Pelzer, Lorna Duncan, et al.
Integrative Cancer Therapies, 2023
- Neoplasms
- Mistletoe
- Viscum album
Wenqing Li, Min Zhang, H. Shu
Environmental Science and Pollution Research, 2005
Schröder L, Hegermann J, Pille P, et al.
2022
- Viscum album
- Arabidopsis Proteins
- Chloroplasts
European mistletoe (Viscum album) is known for its special mode of cellular respiration. It lacks the mitochondrial NADH dehydrogenase complex (Complex I of the respiratory chain) and has restricted capacities to generate mitochondrial adenosine triphosphate (ATP). Here, we present an investigation of the V. album energy metabolism taking place in chloroplasts. Thylakoids were purified from young V. album leaves, and membrane-bound protein complexes were characterized by Blue native polyacrylamide gel electrophoresis as well as by the complexome profiling approach. Proteins were systematically identified by label-free quantitative shotgun proteomics. We identified >1,800 distinct proteins (accessible at https://complexomemap.de/va_leaves), including nearly 100 proteins forming part of the protein complexes involved in the light-dependent part of photosynthesis. The photosynthesis apparatus of V. album has distinct features: (1) comparatively low amounts of Photosystem I; (2) absence of the NDH complex (the chloroplast pendant of mitochondrial Complex I involved in cyclic electron transport (CET) around Photosystem I); (3) reduced levels of the proton gradient regulation 5 (PGR5) and proton gradient regulation 5-like 1 (PGRL1) proteins, which offer an alternative route for CET around Photosystem I; (4) comparable amounts of Photosystem II and the chloroplast ATP synthase complex to other seed plants. Our data suggest a restricted capacity for chloroplast ATP biosynthesis by the photophosphorylation process. This is in addition to the limited ATP supply by the mitochondria. We propose a view on mistletoe's mode of life, according to which its metabolism relies to a greater extent on energy-rich compounds provided by the host trees.
Abstract licence: CC BY
A. Shahabi, M. J. Malakouti, E. Fallahi
Journal of Plant Nutrition, 2005
San-Gwang Hwang, Yi-Ying Li, Huey-Ling Lin
Hortscience, 2015
Bong-Ju Park, Jaeyoung Cho
Journal of the Korean Society for Applied Biological Chemistry, 2011
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.